Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 379 of the 385 references it cites were found in a registry or an index.

Opioid use disorder

Abstract

Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in…

Overview

Integrity signals

Registry

Crossref · 10.1038/s41572-019-0137-5

Cites

379 of 379 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 385 references

Research works printed but not linked: 4

  1. O’Briend, C. P. “Needle freaks”: Psychological Dependence on Shooting Up. in Medical World News, Psychiatry Annual (McGraw Hill, 1974).
  2. Yaksh, T. & Wallace, M. in Goodman and Gilman’s Pharmacological Basis of Therapeutics Ch. 20 (McGraw-Hill Education, 2017).
  3. Gowing, L., Farrell, M., Ali, R. & White, J. M. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst. Rev. 3, CD002024 (2016).
  4. Intstitute of Medicine. Psychosocial interventions for mental and substance use disorders: a framework for establishing evidence-based standards (National Academies Press, 2015).

Cited by

See all 639

Metadata

Authors
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L.
Affiliations
  • King's College London (GB)
  • National Institutes of Health (US)
  • UNSW Sydney (AU)
  • University of Bristol (GB)
  • University of South Florida (US)
  • National Institute on Alcohol Abuse and Alcoholism (US)
  • Brown University (US)
  • University of British Columbia (CA)
  • University of Kentucky (US)
Corresponding author
  • Strang, John
  • Volkow, Nora D.
Venue
Nature Reviews Disease Primers
Published
2020-01-09
Volume
6
Issue
1
Pages
3-3
ISSN
2056-676X (ISSN-L)
OpenAlex
W3000475066
Cited by
639
References
385
Citations by year
2026: 78 · 2025: 129 · 2024: 119 · 2023: 112 · 2022: 101 · 2021: 64 · 2020: 33
FWCI
12.94
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Reviews Disease Primers (publishedVersion)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • National Institute for Health and Care Research (12/136/105, NF-SI-0515-10023, RP-PG-0616-20008)
  • National Institute of General Medical Sciences (P20GM125507)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
opioid use disorder, relapse, opioid overdose deaths, opioid substitution therapy, methadone, buprenorphine, naltrexone, harm reduction, community-based prevention, self-help groups, opioid detoxification, comorbidities
MeSH terms
Humans, Narcotic Antagonists, Opioid-Related Disorders, Opiate Substitution Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opioid use disorder. https://app.cochat.ai/papers/10.1038/s41572-019-0137-5
The paper
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020). Opioid use disorder. Nature Reviews Disease Primers. https://doi.org/10.1038/s41572-019-0137-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.